Unify cell & gene therapy solution

Accelerating and streamlining cell & gene therapy enrollment and coordination across the entire patient journey.

The challenge

Overcoming the complexity of fragmentation in cell and gene therapy

The cell & gene therapy industry struggles with fragmented patient enrollment and coordination solutions. Independent manufacturer processes add complexity, increasing costs and risks while frustrating healthcare providers. This lack of standardization limits access and delays care, emphasizing the urgent need for a unified, streamlined solution to enhance efficiency and improve outcomes.

How we help

Achieve efficient harmony

We enable streamlined interactions with healthcare providers and manufacturers, reducing administrative burden and cost while improving time-to-therapy.

Doubt free data security

We ensure GxP and HIPAA compliance, safeguarding the privacy of patient data and manufacturer intellectual property.

Gain value and agility

Configurable for clinical and commercial therapies, with modular deployment to support developers at various lifecycle stages.

Reinvention in action

Driving efficiency and ethics with existing data

By harnessing historical clinical trial and real-world data, we are making Cell & Gene Therapy trials more efficient and ethical through the use of external control arms.

Our leader

Sanjay Srivastava, Ph.D

Managing Director – Life Sciences, Cell and Gene Lead